Patent Assignment
Reel/Frame 023861/0910
Change of Name
Recorded: 2010-01-29
Pages: 23
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(150)
N-Substituted Nonaryl-Heterocyclo Amidyl Nmda/NR2B Antagonists
Melanocortin-3 Receptor Deficient Cells, Non-Human Transgenic Animals and Methods of Selecting Compounds Which Regulate Body Weight
Patent:
7,321,074 →
Application:
10/129,599 →
Melanin-Concentrating Hormone Analogs
Dna Molecules Encoding Ligand-Gated Ion Channels from Drosophila Melanogaster
Method of Screening for Modulator of LRP5 Activity
Human Sphingosine-1-Phosphate Phosphatase
N-Substituted Nonaryl-Heterocyclic Nmda/NR2B Antagonists
MCH1R Deficient Mice
Echinocandin Process
Melanin-Concentrating Hormone Analogs
Rhesus Monkey, Dog and Ferret Melanin-Concentrating Hormone Type 2 Receptor
Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Electrical Field Stimulation of Eukaryotic Cells
Melanin-Concentrating Hormone Antagonists
Tyrosine Kinase Inhibitors
Method for Monitoring Particle Size
Screening and Selection Methods for Statin Drug Combinations
Androstane 17-Beta-Carboxamides as Androgen Receptor Modulators
Heteroaryl Substituted Tetrazole Modulators of Metabotrophic Glutamate Receptor-5
Histamine Receptor H3 Polynucleotides
Substituted Furopyrimidinones as a Mitotic Kinesin Inhibitors
SUBSTITUTED PYRAZOLO[3,4-d] PYRIMIDINONES AS A MITOTIC KINESIN INHIBITOR
Substituted Oxazolo- and Thiazolopyrimidinones as a Mitotic Kinesin Inhibitor
Substituted Thienopyrimidinones as a Mitotic Kinesin Inhibitor
Heteroaryl Substituted Pyrrole Modulators of Metabotropic Glutamate Receptor-5
Aza-Cyclic Compounds as Modulators of Acetylcholine Receptors
Selective Melanin-Concentrating Hormone Type-1 Receptor Agonists
N-(Benzyl)Aminoalkylcarboxylates, Phosphinates, Phosphonates and Tetrazoles as Edg Receptor Agonists
Hydroxynaphthyridinone Carboxamides Useful as Hiv Integrase Inhibitors
11-Beta-Hydroxysteroid Dehydrogenase 1 Inhibitors Useful for the Treatment of Diabetes, Obesity and Dyslipidemia
Methods of Inhibiting Orthopoxvirus Replication with Nucleoside Compounds
Method of Determining Adenovirus Particle Concentration
Pharmaceutical Treatment Blister Card
Diphenyl Cyclopentyl Amides as Cannabinoid-1 Receptor Inverse Agonists
Substituted 2,3-Diphenyl Pyridines
N-(Substituted Benzyl)-8-Hydroxy-1,6-Naphthyridine-7-Carboxamides Useful as Hiv Integrase Inhibitors
1H-Benzo{F}Indazol-5-Yl Derivatives as Selective Glucocorticoid Receptor Modulators
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Methods of Adenovirus Production
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
Novel Maxi-K Channel Blockers, Methods of Use and Process for Making the Same
Beta-Secretase Inhibitors
Methods of Adenovirus Purification
Aryl-Link-Aryl Substituted Thiazolidine-Dione and Oxazolidine-Dione as Sodium Channel Blockers
Ophthalmic Compositions for Treating Ocular Hypertension
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
(Halo-Benzo Carbonyl)Heterobicyclic P38 Kinase Inhibiting Agents
Piperidino Pyrimidine Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Thionucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Ppar Alpha Selective Compounds for the Treatment of Dyslipidemia and Other Lipid Disorders
Process for Preparing 3-Chloromethyl-1,2,4-Triazolin-5-One
Indoles Having Anti-Diabetic Activity
Piperazine Urea Derivatives as Melanocortin-4 Receptor Agonists
8-Hydroxy-1-Oxo-Tetrahydropyrrolopyrazine Compounds Useful as Hiv Integrase Inhibitors
Using Amines or Amino Acids as Mobile Phase Modifiers in Chromatography
Substituted Pyrimidines
Substituted Bicyclic Thiophene Derivatives, Compositions Containing Such Compounds and Methods of Use
Estrogen Receptor Modulators
Gamma-Aminoamide Modulators of Chemokine Receptor Activity
Radiolabeled Neurokinin-1 Receptor Antagonists
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for Diabetes
Inhibitors of Akt Activity
Process for Making Spirolactone Compounds
Mitotic Kinesin Inhibitors
Tetrahydropyranyl Cyclopentyl Benzylamide Modulators of Chemokine Receptor Activity
1-(Amino)Indanes and (1,2-Dihydro-3-Amino)-Benzofurans, Benzothiophenes and Indoles as Edg Receptor Agonists
Phenylalanine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Tyrosine Kinase Inhibitors
Substituted Amides
Geminally Di-Substituted Nsaid Derivatives as Abeta 42 Lowering Agents
Macrocyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
N-Cyclohexylaminocarbonyl Benzensulfonmide Derivatives
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Process to Branched Ribonucleosides
Selective Non-Steroidal Glucocorticoid Receptor Modulators
Carboxamide Spirohydantoin Cgrp Receptor Antagonists
Benodiazepine Spirohydantoin Cgrp Receptor Antagonists
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Agonists
Bicyclic Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Bicyclic Anilide Spirohydantoin Cgrp Receptor Antagonists
Tetrahydropyranyl Cyclopentyl Heterocyclic Amide Modulators of Chemokine Receptor Activity
Optimized Expression of HPV31 L1 in Yeast
Di-Arylsubstituted Pyrrole Modulators of Metabotropic Glutamate Receptor-5
Cgrp Receptor Antagonists
Androgen Receptor Modulators and Methods of Use Thereof
Di-Aryl Substituted Triazole Modulators of Metabotropic Glutamate Receptor-5
Inhibitors of Akt Activity
Inhibitors of Akt Activity
17-Acetamido-4-Azasteroid Derivatives as Androgen Receptor Modulators
Transgenic Mouse Having an Amyloid Precursor Protein with a Modified Beta Secretase Cleavage Site
Fused Indoles as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Mitotic Kinesin Inhibitors
Prodrugs of Mitotic Kinesin Inhibitors
Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Arylsulfonamide Derivatives
Phenylcarboxylate Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
N-Alkyl Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Sulfonyl Substituted N-(Biarylmethyl) Aminocyclopropanecarboxamides
Hexahydrodiazepinones as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Mitotic Kinesin Inhibitors
Macrocyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
4-Cycloakylaminopyrazolo Pyrimidine Nmda/NR2B Antagonists
17-Heterocyclic-4-Azasteroid Derivatives as Androgen Receptor Modulators
17-Heterocyclic-4-Azasteroid Derivatives as Androgen Receptor Modulators
Ophthalmic Compositions for Treating Ocular Hypertension
Fused Phenylalanine Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Optimized Expression of Hpv 45 L1 in Yeast
Antiprotozoal Imidazopyridine Compounds
Hydroxy Pyridopyrrolopyrazine Dione Compounds Useful as Hiv Integrase Inhibitors
21-Heterocyclic-4-Azasteroid Derivatives as Androgen Receptor Modulators
Aralkyl Amines as Cannabinoid Receptor Modulators
Process for the Preparation of Ccr-2 Antagonists
Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Cyclic Guanidines, Compositions Containing Such Compounds and Methods of Use
Hcv Rna-Dependent Rna Polymerase
2,6-Disubstituted Piperiddines as Modulators
Stereoselective Synthesis of a 4,4-Disubstituted Cyclohexanepropanoic Acid
Synthetic Human Papilloma Virus Genes
Adenovirus Formulations
Biaryl Substituted Triazoles as Sodium Channel Blockers
Dna Molecules Encoding Human Nhl, a Dna Helicase
Pyridazine, Pyrimidine and Pyrazine Ethyne Compounds
Phosphoric Acid Salt of a Dipeptidyl Peptidase-Iv Inhibitor
Process for the Scaleable Purification of Plasmid Dna
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Fluorescence Assay for Measuring the Rate of Cholesterol Ester Transfer
Mitotic Kinesin Inhibitors
Hydroisoindoline Tachykinin Receptor Antagonists
Process for Preparing Fluoroleucine Alkyl Esters
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Cgrp Receptor Antagonists
Trace Amine Receptor 1 of the African Green Monkey
Process for Making Fluorinated 4-Azasteroid Derivatives
Novel Spirochromanone Derivatives
Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Process for Making Fluoroleucine Ethyl Esters
Fluorinated 4-Azasteroids as Androgen Receptor Modulators
Phenyl Carboxamide Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Polymorphs of an Androgen Receptor Modulator
Carboxamide Spirolactam Cgrp Receptor Antagonists
Inhibitors of Akt Activity
Indoles Having Anti-Diabetic Activity
Hydroisoindoline Tachykinin Receptor Antagonists
Cgrp Receptor Antagonists
Antidiabetic Bicyclic Compounds
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2011
From: BANYU PHARMACEUTICAL CO., LTD.
To: MSD K.K.
Reel/Frame 025920/0079 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest
Jul 16, 2014
From: MERCK SHARP & DOHME CORP.
To: MERIAL LIMITED
Reel/Frame 033323/0013 →